Literature DB >> 32475834

Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon et al.

Maximilian F Konig1, Milena Gianfrancesco2, Jinoos Yazdany2, Philip C Robinson3.   

Abstract

Entities:  

Keywords:  epidemiology; hydroxychloroquine; lupus erythematosus, systemic

Mesh：

Substances：

Year:  2020        PMID： 32475834      PMCID： PMC7704575          DOI： 10.1136/annrheumdis-2020-217990

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   27.973


× No keyword cloud information.
  9 in total

1.  Hydroxychloroquine (HCQ) in lupus pregnancy: double-blind and placebo-controlled study.

Authors:  R A Levy; V S Vilela; M J Cataldo; R C Ramos; J L Duarte; B R Tura; E M Albuquerque; N R Jesús
Journal:  Lupus       Date:  2001       Impact factor: 2.911

2.  Hydroxychloroquine in lupus pregnancy.

Authors:  Megan E B Clowse; Laurence Magder; Frank Witter; Michelle Petri
Journal:  Arthritis Rheum       Date:  2006-11

3.  2020 American College of Rheumatology Guideline for the Management of Reproductive Health in Rheumatic and Musculoskeletal Diseases.

Authors:  Lisa R Sammaritano; Bonnie L Bermas; Eliza E Chakravarty; Christina Chambers; Megan E B Clowse; Michael D Lockshin; Wendy Marder; Gordon Guyatt; D Ware Branch; Jill Buyon; Lisa Christopher-Stine; Rachelle Crow-Hercher; John Cush; Maurice Druzin; Arthur Kavanaugh; Carl A Laskin; Lauren Plante; Jane Salmon; Julia Simard; Emily C Somers; Virginia Steen; Sara K Tedeschi; Evelyne Vinet; C Whitney White; Jinoos Yazdany; Medha Barbhaiya; Brittany Bettendorf; Amanda Eudy; Arundathi Jayatilleke; Amit Aakash Shah; Nancy Sullivan; Laura L Tarter; Mehret Birru Talabi; Marat Turgunbaev; Amy Turner; Kristen E D'Anci
Journal:  Arthritis Rheumatol       Date:  2020-02-23       Impact factor: 10.995

4.  Risk and protective factors for thrombosis in systemic lupus erythematosus: results from a large, multi-ethnic cohort.

Authors:  R Kaiser; C M Cleveland; L A Criswell
Journal:  Ann Rheum Dis       Date:  2008-09-09       Impact factor: 19.103

5.  Hydroxychloroquine and pregnancy on lupus flares in Korean patients with systemic lupus erythematosus.

Authors:  J H Koh; H S Ko; S-K Kwok; J H Ju; S-H Park
Journal:  Lupus       Date:  2014-10-10       Impact factor: 2.911

6.  Baseline use of hydroxychloroquine in systemic lupus erythematosus does not preclude SARS-CoV-2 infection and severe COVID-19.

Authors:  Maximilian F Konig; Alfred Hj Kim; Marc H Scheetz; Elizabeth R Graef; Jean W Liew; Julia Simard; Pedro M Machado; Milena Gianfrancesco; Jinoos Yazdany; Daman Langguth; Philip C Robinson
Journal:  Ann Rheum Dis       Date:  2020-05-07       Impact factor: 19.103

7.  Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.

Authors:  Lionel Carbillon; Amélie Benbara; Jeremy Boujenah
Journal:  Ann Rheum Dis       Date:  2020-05-31       Impact factor: 19.103

8.  Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry.

Authors:  Milena Gianfrancesco; Kimme L Hyrich; Jinoos Yazdany; Pedro M Machado; Philip C Robinson; Sarah Al-Adely; Loreto Carmona; Maria I Danila; Laure Gossec; Zara Izadi; Lindsay Jacobsohn; Patricia Katz; Saskia Lawson-Tovey; Elsa F Mateus; Stephanie Rush; Gabriela Schmajuk; Julia Simard; Anja Strangfeld; Laura Trupin; Katherine D Wysham; Suleman Bhana; Wendy Costello; Rebecca Grainger; Jonathan S Hausmann; Jean W Liew; Emily Sirotich; Paul Sufka; Zachary S Wallace
Journal:  Ann Rheum Dis       Date:  2020-05-29       Impact factor: 19.103

9.  EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome.

Authors:  L Andreoli; G K Bertsias; N Agmon-Levin; S Brown; R Cervera; N Costedoat-Chalumeau; A Doria; R Fischer-Betz; F Forger; M F Moraes-Fontes; M Khamashta; J King; A Lojacono; F Marchiori; P L Meroni; M Mosca; M Motta; M Ostensen; C Pamfil; L Raio; M Schneider; E Svenungsson; M Tektonidou; S Yavuz; D Boumpas; A Tincani
Journal:  Ann Rheum Dis       Date:  2016-07-25       Impact factor: 19.103
  9 in total
  1 in total

Review 1.  SARS-CoV-2 and Systemic Lupus Erythematosus.

Authors:  Aikaterini Thanou; Amr H Sawalha
Journal:  Curr Rheumatol Rep       Date:  2021-01-28       Impact factor: 4.592
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.